Fingerprint
Dive into the research topics of 'Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): A randomised, placebo-controlled, phase 3 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically